Trial Profile
Phase 4 Study of Mirtazapine in Functional Dyspepsia Patients With Weight Loss.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- 10 May 2021 This trial has been completed in Belgium, according to European Clinical Trials Database record. (2012-09-11).
- 21 May 2013 Results presented at the Digestive Disease Week 2013.
- 12 Nov 2010 Additional lead trial centre and investigator (Tack J), actual initiation date (September 2006) and planned end date (December 2011) identified as reported by ClinicalTrials.gov.